Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

20.29 +1.68 (+9.00%)

Streaming Delayed Price Updated: 3:43 PM EST, Nov 24, 2025 Add to My Watchlist

Price and Volume

Volume	3,280,353
Open	18.95
Bid (Size)	20.26 (200)
Ask (Size)	20.31 (900)
Prev. Close	18.61
Today's Range	18.40 - 20.65
52wk Range	4.760 - 18.98
Shares Outstanding	144,311,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting

Today 7:30 EST

Record-setting presence at ASH reflects widespread recognition of clonoSEQ as a standard-of-care tool for personalizing patient care and accelerating drug development

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

November 06, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Performance

YTD	+227.7%	+227.7%
1 Month	+17.8%	+17.8%
3 Month	+60.1%	+60.1%
6 Month	+121.9%	+121.9%
1 Year	+263.5%	+263.5%

More News

Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results

November 05, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys ↗

November 04, 2025

Via Benzinga

Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025

October 15, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Tesla To $300? Here Are 10 Top Analyst Forecasts For Monday ↗

October 13, 2025

Via Benzinga

A Glimpse Into The Expert Outlook On Adaptive Biotechnologies Through 4 Analysts ↗

September 30, 2025

Via Benzinga

United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday ↗

September 30, 2025

Via Benzinga

Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

August 27, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies (NASDAQ:ADPT) Fits Minervini's Trend Template with Strong Growth Momentum ↗

August 09, 2025

Via Chartmill

Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday ↗

August 06, 2025

Via The Motley Fool

Adaptive (ADPT) Q2 Revenue Surges 36% ↗

August 06, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 05, 2025

Via Benzinga

Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results

August 05, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics ↗

July 26, 2025

Via Benzinga

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025

July 15, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®

July 01, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Cathie Wood's Ark Invest Adds Airbnb, AMD, Shopify To Portfolio, Slashes Stake In Circle Internet ↗

June 21, 2025

Via Benzinga

Assessing Adaptive Biotechnologies: Insights From 5 Financial Analysts ↗

June 18, 2025

Via Benzinga

ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT) – A High-Growth Stock Meeting Minervini’s Trend Template ↗

June 14, 2025

Via Chartmill

Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration ↗

May 30, 2025

Via Benzinga

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers

May 30, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Frequently Asked Questions

Is Adaptive Biotechnologies Corporation - Common Stock publicly traded?

Yes, Adaptive Biotechnologies Corporation - Common Stock is publicly traded.

What exchange does Adaptive Biotechnologies Corporation - Common Stock trade on?

Adaptive Biotechnologies Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Adaptive Biotechnologies Corporation - Common Stock?

The ticker symbol for Adaptive Biotechnologies Corporation - Common Stock is ADPT on the Nasdaq Stock Market

What is the current price of Adaptive Biotechnologies Corporation - Common Stock?

The current price of Adaptive Biotechnologies Corporation - Common Stock is 20.29

When was Adaptive Biotechnologies Corporation - Common Stock last traded?

The last trade of Adaptive Biotechnologies Corporation - Common Stock was at 11/24/25 03:43 PM ET

What is the market capitalization of Adaptive Biotechnologies Corporation - Common Stock?

The market capitalization of Adaptive Biotechnologies Corporation - Common Stock is 2.93B

How many shares of Adaptive Biotechnologies Corporation - Common Stock are outstanding?

Adaptive Biotechnologies Corporation - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.